Works matching IS 11738804 AND DT 2020 AND VI 34 AND IP 6

Results: 10

Acknowledgement to Referees.

Published in:: BioDrugs, 2020, v. 34, n. 6, p. 701, doi. 10.1007/s40259-020-00455-6
Publication type:: Article

Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 763, doi. 10.1007/s40259-020-00453-8

By:

Fuller-Carter, Paula I.;
Basiri, Hamed;
Harvey, Alan R.;
Carvalho, Livia S.

Publication type:

Article

European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 783, doi. 10.1007/s40259-020-00452-9

By:

Barbier, Liese;
Simoens, Steven;
Vulto, Arnold G.;
Huys, Isabelle

Publication type:

Article

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 713, doi. 10.1007/s40259-020-00451-w

By:

Almradi, Ahmed;
Hanzel, Jurij;
Sedano, Rocio;
Parker, Claire E.;
Feagan, Brian G.;
Ma, Christopher;
Jairath, Vipul

Publication type:

Article

Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 749, doi. 10.1007/s40259-020-00450-x

By:

Taha, Tarek;
Reiss, Ari;
Amit, Amnon;
Perets, Ruth

Publication type:

Article

The Immunotherapy Landscape in Renal Cell Carcinoma.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 733, doi. 10.1007/s40259-020-00449-4

By:

Brown, Landon C.;
Desai, Kunal;
Zhang, Tian;
Ornstein, Moshe C.

Publication type:

Article

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 705, doi. 10.1007/s40259-020-00448-5

By:

Atal, Shubham;
Fatima, Zeenat;
Balakrishnan, Sadasivam

Publication type:

Article

Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 809, doi. 10.1007/s40259-020-00447-6

By:

Wiland, Piotr;
Jeka, Sławomir;
Dokoupilová, Eva;
Brandt-Jürgens, Jan;
Miranda Limón, Juan Manuel;
Cantalejo Moreira, Miguel;
Cabello, Raul Veiga;
Jauch-Lembach, Julia;
Thakur, Anjali;
Haliduola, Halimuniyazi;
Brueckmann, Ines;
Gaylis, Norman B.

Publication type:

Article

Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 723, doi. 10.1007/s40259-020-00446-7

By:

Alvarez, Daniel F.;
Wolbink, Gertjan;
Cronenberger, Carol;
Orazem, John;
Kay, Jonathan

Publication type:

Article

European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice.

Published in:

BioDrugs, 2020, v. 34, n. 6, p. 797, doi. 10.1007/s40259-020-00440-z

By:

Barbier, Liese;
Simoens, Steven;
Vulto, Arnold G.;
Huys, Isabelle

Publication type:

Article